Characterization of cervical lymph-nodes using a multi-parametric and multi-modal approach for an early prediction of tumor response to chemo-radiotherapy

Physica Medica

Volumn 32, Issue 12, 2016, Pages 1672-1680

  Scalco, Elisa ^a   Marzi, Simona ^b   Sanguineti, Giuseppe ^b   Vidiri, Antonello ^b   Rizzo, Giovanna ^a  

^a CNR   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

DW MRI; Head and neck lymph nodes; T2w MRI; Texture analysis

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER CONTROL; CERVICAL LYMPH NODE; CHEMORADIOTHERAPY; CLASSIFICATION; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; QUANTITATIVE ANALYSIS; TREATMENT FAILURE; TREATMENT RESPONSE; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY; CARCINOMA, SQUAMOUS CELL; DIAGNOSTIC IMAGING; DISCRIMINANT ANALYSIS; HEAD AND NECK NEOPLASMS; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; MULTIMODAL IMAGING; PATHOLOGY; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DISCRIMINANT ANALYSIS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LINEAR MODELS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIMODAL IMAGING; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84994852899     PISSN: 11201797     EISSN: 1724191X     Source Type: Journal    
DOI: 10.1016/j.ejmp.2016.09.003     Document Type: Article

References (34)

1. [1] Bonner, J.A., Harari, P.M., Giralt, J., Azarnia, N., Shin, D.M., Cohen, R.B., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006), 567–578.
2. [2] Hermann, R.M., Christiansen, H., Rödel, R.M., Lymph node positive head and neck carcinoma after curative radiochemotherapy: a long lasting debate on elective post-therapeutic neck dissections comes to a conclusion. Cancer Radiothérapie J La Société Fr Radiothérapie Oncol 17 (2013), 323–331.
3. [3] King, A.D., Yu, K.-H., Mo, F.K.F., Law, B.K.H., Yuen, T.W.C., Bhatia, K.S., et al. Cervical nodal metastases from head and neck squamous cell carcinoma: MRI criteria for treatment assessment. Head Neck 38 (2016), E1598–E1604.
4. [4] Hauser, T., Essig, M., Jensen, A., Laun, F.B., Münter, M., Maier-Hein, K.H., et al. Prediction of treatment response in head and neck carcinomas using IVIM-DWI: evaluation of lymph node metastasis. Eur J Radiol 83 (2014), 783–787.
5. [5] Davuluri, R., Krase, J.M., Cui, H., Goyal, U.D., Cheung, M.K., Hsu, C.C., et al. Image guided volumetric response during chemoradiotherapy for head and neck squamous cell carcinoma as a predictor of disease outcomes. Am J Otolaryngol, 2016 in press.
6. [6] Ding, Y., Hazle, J.D., Mohamed, A.S.R., Frank, S.J., Hobbs, B.P., Colen, R.R., et al. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot study. NMR Biomed 28 (2015), 1645–1654.
7. [7] Tang, C., Fuller, C.D., Garden, A.S., Awan, M.J., Colen, R.R., Morrison, W.H., et al. Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response. Oral Oncol 51 (2015), 195–201.
8. [8] Sanguineti, G., Ricchetti, F., Wu, B., Agrawal, N., Gourin, C., Agbahiwe, H., et al. Volumetric change of human papillomavirus-related neck lymph nodes before, during, and shortly after intensity-modulated radiation therapy. Head Neck 34 (2012), 1640–1647.
9. [9] Zerbetto, Belli.C., Raso, F., Broggi, R., Chiara, S., Cattaneo, A., Di Muzio, G.M., Dell'oca, N., Calandrino, I., MLF, R., Early volume variation of positive lymph nodes assessed by in-room mega voltage CT images predicts risk of loco-regional relapses in head and neck cancer patients treated with intensity-modulated radiotherapy. Acta Oncol 54 (2015), 1490–1495.
10. [10] Vandecaveye, V., Dirix, P., De Keyzer, F., Op De Beeck, K., Vander Poorten, V., Roebben, I., et al. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 20 (2010), 1703–1714.
11. [11] Vandecaveye, V., De Keyzer, F., Nuyts, S., Deraedt, K., Dirix, P., Hamaekers, P., et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 67 (2007), 960–971.
12. [12] Vandecaveye, V., De Keyzer, F., Dirix, P., Lambrecht, M., Nuyts, S., Hermans, R., Applications of diffusion-weighted magnetic resonance imaging in head and neck squamous cell carcinoma. Neuroradiology 52 (2010), 773–784.
13. [13] Hatakenaka, M., Nakamura, K., Yabuuchi, H., Shioyama, Y., Matsuo, Y., Ohnishi, K., et al. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys 81 (2011), 339–345.
14. [14] Kato, H., Kanematsu, M., Tanaka, O., Mizuta, K., Aoki, M., Shibata, T., et al. Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect. Eur Radiol 19 (2009), 103–109.
15. [15] Chawla, S., Kim, S., Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck. Am J Roentgenol 200 (2013), 35–43.
16. [16] King, A.D., Mo, F.K.F., Yu, K.-H., Yeung, D.K.W., Zhou, H., Bhatia, K.S., et al. Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 20 (2010), 2213–2220.
17. [17] Tyagi, N., Riaz, N., Hunt, M., Wengler, K., Hatzoglou, V., Young, R., et al. Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma. Med Phys 43 (2015), 137–147.
18. [18] Surov, A., Stumpp, P., Meyer, H.J., Gawlitza, M., Höhn, A.-K., Boehm, A., et al. Simultaneous 18F-FDG-PET/MRI: associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma. Oral Oncol 58 (2016), 14–20.
19. [19] Jansen, J.F., Lu, Y., Gupta, G., Lee, N.Y., Stambuk, H.E., Mazaheri, Y., et al. Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancer. World J Radiol 8 (2016), 90–97.
20. [20] Edge, S.B., Compton, C.C., The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 17, 2010 1471-4.
21. [21] Fedorov, A., Beichel, R., Kalpathy-Cramer, J., Finet, J., Fillion-Robin, J.-C., Pujol, S., et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 30 (2012), 1323–1341.
22. [22] Tustison, N.J., Gee, J.C., N4ITK: Nick's N3 ITK implementation for MRI Bias field correction. Insight J, 2009, 1–8.
23. [23] Nyul, L.G., Udupa, J.K., Zhang, X., New variants of a method of MRI scale standardization. IEEE Trans Med Imaging 19 (2000), 143–150.
24. [24] Klein, S., Staring, M., Murphy, K., Viergever, M.A., Pluim, J.P.W., Elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 29 (2010), 196–205.
25. [25] Moriconi S, Scalco E, Rancati T, Messina A, Giandini T, Valdagni R, et al. Application and evaluation of wavelet-based surface reconstruction for contour propagation in Radiotherapy. Proc. MICCAI Work. Imaging Comput. Assist. Radiat. Ther., Munich, Germany; 2015, p. 58–65.
26. [26] Murata, S., Saito, T., The variogram method for a fractal model of a rock joint surface. Geotech Geol Eng 17 (1999), 197–210.
27. [27] Lambrecht, M., Van Calster, B., Vandecaveye, V., De Keyzer, F., Roebben, I., Hermans, R., et al. Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma. Radiother Oncol 110 (2014), 429–434.
28. [28] Scalco, E., Fiorino, C., Cattaneo, G.M., Sanguineti, G., Rizzo, G., Texture analysis for the assessment of structural changes in parotid glands induced by radiotherapy. Radiother Oncol 109 (2013), 384–387.
29. [29] Mayerhoefer, M.E., Szomolanyi, P., Jirak, D., Materka, A., Trattnig, S., Effects of MRI acquisition parameter variations and protocol heterogeneity on the results of texture analysis and pattern discrimination: An application-oriented study. Med Phys, 36, 2009, 1236.
30. [30] Kan, T., Kodani, K., Michimoto, K., Fujii, S., Ogawa, T., Radiation-induced damage to microstructure of parotid gland: evaluation using high-resolution magnetic resonance imaging. Int J Radiat Oncol Biol Phys 77 (2010), 1030–1038.
31. [31] King, A.D., Mo, F.K.F., Yu, K.-H., Yeung, D.K.W., Zhou, H., Bhatia, K.S., et al. Head and neck squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 20 (2010), 2213–2220.
32. [32] Matoba, M., Tuji, H., Shimode, Y., Toyoda, I., Kuginuki, Y., Miwa, K., et al. Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy. AJNR Am J Neuroradiol 35 (2014), 379–385.
33. [33] Noij, D.P., Boerhout, E.J., Pieters-Van Den Bos, I.C., Comans, E.F., Oprea-Lager, D., Reinhard, R., et al. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: A feasibility study. Eur J Radiol 83 (2014), 1144–1151.
34. [34] Yip, S.S.F., Aerts, H.J.W.L., Applications and limitations of radiomics. Phys Med Biol 61 (2016), R150–R166.